Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 21, 2026; 32(43): 123529
Published online Nov 21, 2026. doi: 10.3748/wjg.123529
Published online Nov 21, 2026. doi: 10.3748/wjg.123529
Table 1 Evolution and key milestones in natural orifice transluminal endoscopic surgery
| Ref. | Date | Model or setting | Access route | Procedure/innovation | Key contribution/outcomes |
| Kalloo et al[1] | 2000 | Porcine model | Trans-gastric | Diagnostic peritoneoscopy | First proof-of-concept of transluminal endoscopic access to the peritoneal cavity |
| Rao et al[2] | 2008 | Human | Trans-gastric | Appendectomy | First human NOTES procedure |
| Rattner et al[3] | 2006 | Consensus group | - | Established safety framework | Laid research and training foundations for clinical NOTES |
| Jamshidi et al[10] | 2009 | Human | Trans-gastric | Human magnetic compression gastroenterostomy | First human magnetic-assisted transluminal anastomosis |
| Liu et al[7] | 2013-2014 | Human | Trans-gastric | Ovarian cystectomy | First pure transgastric human NOTES |
| Liu et al[5] | 2015 | Human | Trans-rectal | Gallbladder preserving cholecystolithotomy | First pure organ-preserving NOTES procedure |
| Liu et al[6], Liu et al[7], Liu et al[8], Wang et al[9] | 2018-2020 | Clinical | Trans-rectal, trans-gastric, trans-vaginal | Appendectomy, gastroenterostomy | Expansion to transluminal therapeutic applications |
| Zhao et al[16] | 2021-2023 | Human | Trans-rectal | Balloon-assisted access and closure | Development of detachable balloon system reducing peritoneal contamination risk |
| Jamshidi et al[10], Ryou et al[11], Ryou et al[12], Thigpen et al[13], Simsek et al[15] | 2023-2025 | Clinical and Experimental | Trans-rectal, trans-gastric, trans-vaginal | Gallbladder, liver, pancreas, mediastinal interventions | Integration of robotics, magnetic platforms, and AI-assisted navigation into NOTES |
Table 2 Current and emerging clinical and experimental applications of natural orifice transluminal endoscopic surgery across organ systems
| Ref. | Organ system/application area | Representative procedures | Preferred access route | Stage of development | Key technical features | Outcomes/technical success |
| Liu et al[5], Hao et al[14], Dubcenco et al[20], Shang et al[43] | Gallbladder | Gallbladder-preserving cholecystolithotomy; cholecystectomy | Transrectal, transgastric | Early clinical to selected clinical application | Transparent cap assistance; transrectal or transgastric access; endoscopic gallstone retrieval; endoscopic closure using clips or OTSC when needed | Reported as feasible in selected patients; long-term recurrence, gallbladder function, and comparative outcomes require further study |
| Steele et al[45], Hazey et al[46], Chen et al[47], Liu et al[48], Chen et al[49] | Liver | Transgastric peritoneoscopy and liver biopsy; hepatic cyst deroofing or sclerotherapy | Transgastric, trans-sigmoid | Experimental to early clinical | Transluminal access to the peritoneal cavity; biopsy forceps or cyst intervention; electrocautery or endoscopic hemostasis when needed | Liver biopsy and hepatic cyst interventions have been reported as feasible in early human experience and selected cases; evidence remains limited |
| Wang et al[51], Matthes et al[52] | Pancreas | Pancreatic tail resection; pancreatic tumor enucleation | Transgastric | Experimental, animal models | Transgastric access; endoscopic dissection; clip closure; endoscopic management of minor bleeding or injury | Demonstrated technical feasibility in porcine models; pancreatic leak and adjacent organ injury remain important safety concerns |
| Liu et al[8] | Appendix/cecum | Transcecal appendectomy for appendiceal polyps | Transcecal | Limited clinical experience | Direct cecal access; flexible endoscopic resection; endoscopic closure of the cecal defect | Reported as feasible in selected clinical cases; broader safety and reproducibility require further evaluation |
| Liu et al[6], Pham et al[21], Ge and Thompson[22], Jin et al[23] | Stomach/small bowel | Pure NOTES gastroenterostomy; endoscopic suturing or defect closure related to transluminal intervention | Transgastric | Early clinical and device-development stage | Submucosal tunneling or transluminal access; endoscopic suturing; OTSC or clip-assisted closure | Early reports support feasibility, but outcomes vary by indication, technique, and available closure platform |
| Inoue et al[32], Liu et al[33], Inoue et al[37], Vespa et al[38], Nabi et al[39], Draganov et al[40], Harlow et al[41], Grimaldi et al[42] | Third-space endoscopy/esophagus | POEM; modified POEM; POEM-F; ESD and traction-assisted ESD | Transoral | Established for selected indications; evolving for expanded applications | Submucosal tunneling; selective or full-thickness myotomy; endoscopic fundoplication; traction-assisted submucosal dissection | Established for selected luminal and third-space indications such as achalasia and early gastrointestinal neoplasia; reflux and long-term outcomes remain procedure-dependent |
- Citation: Ullah S, Ali FS, Han YL, Liu BR, Thosani N, Liao Z. Natural orifice transluminal endoscopic surgery: The true frontier of gastrointestinal endoscopy. World J Gastroenterol 2026; 32(43): 123529
- URL: https://www.wjgnet.com/1007-9327/full/v32/i43/123529.htm
- DOI: https://dx.doi.org/10.3748/wjg.123529